Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.25 trillion and total revenue of $115.82 billion.
Market Cap
1.25T
Revenue
115.82B
Profits
-36.06B
PE Ratio
n/a
Profit Margin
-31.14%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.32B | -0.24% | 775,071 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 74.84B | -7.75% | 18,794,808 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 73.76B | 1.69% | 615,062 | 15.53B |
| 4 | ARGX | argenx SE | 58.81B | 1.93% | 430,066 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 42.84B | -3.76% | 1,631,756 | - |
| 6 | ONC | BeOne Medicines AG | 41.25B | 0.31% | 319,917 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.45B | -0.39% | 2,434,244 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.97B | 1.84% | 1,356,363 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.66B | -0.70% | 5,739,960 | 7.53M |
| 10 | BNTX | BioNTech SE | 24.05B | -1.96% | 899,389 | 3.03B |
| 11 | INSM | Insmed Incorporated | 22.98B | 1.35% | 3,686,126 | 1.14B |
| 12 | INCY | Incyte Corporation | 22.85B | -1.23% | 2,459,573 | 5.82B |
| 13 | GMAB | Genmab A/S | 22.35B | -1.77% | 6,596,368 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.02B | -1.97% | 862,208 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.85B | -0.87% | 1,091,810 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.45B | -0.88% | 2,031,706 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.81B | 0.23% | 5,875,830 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.09B | 1.24% | 3,710,306 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.93B | -2.02% | 790,536 | 830.81M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.45B | 1.30% | 1,774,271 | 1.66B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.47B | 0.57% | 330,282 | 1.28B |
| 22 | TECH | Bio-Techne Corporation | 11.36B | -0.21% | 2,893,249 | 1.22B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.88B | -2.29% | 3,718,989 | 3.41B |
| 24 | TWST | Twist Bioscience Corporation | 10.47B | -18.55% | 8,557,505 | 431.80M |
| 25 | IBRX | ImmunityBio, Inc. | 10.27B | -6.65% | 16,886,968 | 165.79M |
| 26 | PCVX | Vaxcyte, Inc. | 9.93B | -9.65% | 10,160,223 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 9.67B | -2.40% | 352,142 | 440.48M |
| 28 | AXSM | Axsome Therapeutics, Inc. | 9.13B | -1.55% | 1,367,835 | 776.57M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 8.97B | -1.38% | 635,716 | 281.99M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 8.81B | -3.52% | 960,714 | 105.00M |
| 31 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.69B | -1.30% | 1,675,592 | 669.50M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.53B | -2.15% | 3,228,905 | 67.67M |
| 33 | ABVX | ABIVAX Société Anonyme | 7.90B | -3.83% | 2,000,597 | 5.33M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 7.82B | -1.21% | 435,167 | 7.46M |
| 35 | CAI | Caris Life Sciences, Inc. | 7.76B | -9.66% | 4,748,029 | 989.61M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.40B | -3.19% | 2,412,371 | 799.54M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | 1.15% | 2,193,060 | 874.09M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.06B | -13.60% | 4,252,338 | - |
| 39 | IMVT | Immunovant, Inc. | 6.63B | -3.43% | 1,674,006 | - |
| 40 | BLTE | Belite Bio, Inc | 6.27B | -2.24% | 190,257 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.25B | -1.82% | 992,872 | 239.92M |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 5.92B | -3.20% | 163,743 | 290.54M |
| 43 | IOVA | Iovance Biotherapeutics, Inc. | 5.87B | -8.41% | 18,953,941 | 324.97M |
| 44 | KOD | Kodiak Sciences Inc. | 5.79B | -1.57% | 1,483,106 | - |
| 45 | CGON | CG Oncology, Inc. | 5.64B | -7.38% | 774,380 | 6.23M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.32B | 0.08% | 1,264,990 | 1.01B |
| 47 | ORKA | Oruka Therapeutics, Inc. | 5.31B | -4.98% | 1,122,585 | - |
| 48 | TVTX | Travere Therapeutics, Inc. | 5.28B | -2.93% | 3,108,042 | 591.33M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.27B | -1.59% | 2,383,803 | - |
| 50 | CRSP | CRISPR Therapeutics AG | 5.22B | -5.82% | 2,628,179 | 13.39M |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.17B | -2.19% | 1,865,496 | - |
| 52 | MIRM | Mirum Pharmaceuticals, Inc. | 5.15B | -2.68% | 1,146,951 | 618.07M |
| 53 | ERAS | Erasca, Inc. | 5.00B | -2.85% | 8,043,035 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 4.79B | -1.68% | 2,481,380 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | -3.00% | 1,347,792 | 1.90M |
| 56 | MANE | Veradermics, Incorporated | 4.55B | -8.34% | 736,723 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.35B | -0.69% | 1,624,861 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.26B | -4.57% | 9,789,853 | 66.17M |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.11B | -3.35% | 3,879,840 | 10.35M |
| 60 | TLX | Telix Pharmaceuticals Limited | 3.76B | -0.92% | 235,101 | 890.79M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.69B | -5.11% | 4,351,222 | 53.81M |
| 62 | LEGN | Legend Biotech Corporation | 3.63B | -0.32% | 1,345,412 | 1.27B |
| 63 | PBLS | Parabilis Medicines, Inc. | 3.57B | -2.27% | 979,215 | 148.00K |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | -2.66% | 2,788,083 | 7.50M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.53B | -3.76% | 802,454 | 234.13M |
| 66 | CELC | Celcuity Inc. | 3.49B | -3.22% | 1,563,199 | - |
| 67 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | -1.84% | 1,666,303 | 1.14B |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.31B | -3.07% | 7,109,613 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.25B | -0.47% | 432,429 | 606.33M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.11B | -6.77% | 2,333,093 | - |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.09B | -1.86% | 824,849 | 117.00M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.08B | -3.16% | 3,674,486 | 3.60M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.01B | -4.89% | 2,573,026 | 463.98M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.88B | -0.26% | 4,101,426 | - |
| 75 | ZLAB | Zai Lab Limited | 2.87B | -0.16% | 1,214,237 | 449.61M |
| 76 | MBX | MBX Biosciences, Inc. | 2.74B | -2.77% | 366,626 | - |
| 77 | PGEN | Precigen, Inc. | 2.70B | -2.45% | 5,140,066 | 85.72M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 2.66B | -2.32% | 1,266,308 | 7.12M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.52B | -1.71% | 2,522,986 | 156.04M |
| 80 | RXRX | Recursion Pharmaceuticals, Inc. | 2.48B | -3.14% | 71,105,964 | 54.86M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.43B | -4.86% | 1,768,235 | 158.00K |
| 82 | IRON | Disc Medicine, Inc. | 2.37B | -2.65% | 1,422,377 | - |
| 83 | NRIX | Nurix Therapeutics, Inc. | 2.35B | -1.22% | 1,154,218 | 36.77M |
| 84 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -1.40% | 507,277 | 959.90M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -2.49% | 3,982,641 | - |
| 86 | ADMA | ADMA Biologics, Inc. | 2.28B | 0.69% | 2,100,142 | 512.28M |
| 87 | IMNM | Immunome, Inc. | 2.19B | -8.79% | 2,314,181 | 4.02M |
| 88 | PHVS | Pharvaris N.V. | 2.18B | 2.07% | 778,389 | - |
| 89 | VERA | Vera Therapeutics, Inc. | 2.12B | -1.37% | 2,395,808 | - |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -0.19% | 699,165 | 311.51M |
| 91 | ADRX | ADARx Pharmaceuticals, Inc. | 2.08B | -2.47% | 1,034,935 | 6.13M |
| 92 | VRDN | Viridian Therapeutics, Inc. | 2.06B | -4.11% | 2,196,904 | 71.13M |
| 93 | VCEL | Vericel Corporation | 2.05B | -2.48% | 669,044 | 306.30M |
| 94 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.04B | -7.86% | 3,613,442 | 208.78M |
| 95 | URGN | UroGen Pharma Ltd. | 2.03B | -3.16% | 764,455 | 188.73M |
| 96 | FTRE | Fortrea Holdings Inc. | 1.98B | -1.56% | 2,650,659 | 2.68B |
| 97 | VIR | Vir Biotechnology, Inc. | 1.96B | -1.53% | 2,586,736 | 303.23M |
| 98 | GPCR | Structure Therapeutics Inc. | 1.96B | -0.43% | 1,421,894 | - |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 1.94B | -5.79% | 1,215,986 | - |
| 100 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -0.64% | 452,120 | 1.13B |
| 101 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 1.50% | 1,278,353 | 98.34M |
| 102 | TRVI | Trevi Therapeutics, Inc. | 1.88B | -3.94% | 4,998,909 | - |
| 103 | NVAX | Novavax, Inc. | 1.87B | -9.87% | 19,413,047 | 413.80M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.84B | -3.15% | 309,986 | - |
| 105 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | -1.03% | 2,691,453 | 1.97B |
| 106 | BHVN | Biohaven Ltd. | 1.82B | -6.86% | 3,054,390 | - |
| 107 | ZYME | Zymeworks Inc. | 1.82B | -2.14% | 1,465,972 | 37.13M |
| 108 | XNCR | Xencor, Inc. | 1.81B | -4.96% | 1,245,800 | 104.97M |
| 109 | MESO | Mesoblast Limited | 1.81B | -4.29% | 404,696 | 120.25M |
| 110 | GENB | Generate Biomedicines, Inc. | 1.77B | -0.79% | 1,170,054 | 26.48M |
| 111 | ABSI | Absci Corporation | 1.76B | -10.93% | 5,882,905 | 1.56M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -3.20% | 357,596 | 1.00M |
| 113 | NTLA | Intellia Therapeutics, Inc. | 1.73B | -2.98% | 7,951,766 | 59.51M |
| 114 | NUVB | Nuvation Bio Inc. | 1.71B | -1.41% | 6,653,858 | 169.90M |
| 115 | SEPN | Septerna, Inc. | 1.66B | -5.81% | 491,197 | 98.88M |
| 116 | BRVE | Braveheart Bio, Inc. | 1.62B | -7.31% | 590,322 | - |
| 117 | OCUL | Ocular Therapeutix, Inc. | 1.61B | 1.24% | 2,807,102 | 52.06M |
| 118 | QURE | uniQure N.V. | 1.60B | 1.14% | 2,824,804 | 18.67M |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.57B | -3.75% | 1,167,351 | 27.59M |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.55B | -2.58% | 1,135,156 | 252.25M |
| 121 | IMCR | Immunocore Holdings plc | 1.52B | -0.14% | 662,603 | 430.78M |
| 122 | INVA | Innoviva, Inc. | 1.50B | 0.92% | 679,632 | 440.00M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.49B | -3.23% | 235,744 | 20.00M |
| 124 | GHRS | GH Research PLC | 1.48B | -2.93% | 495,431 | - |
| 125 | MAZE | Maze Therapeutics, Inc. | 1.47B | - | 682,837 | 20.00M |
| 126 | KRSA | Korsana Biosciences, Inc. | 1.45B | 3.42% | 42,626 | - |
| 127 | AAPG | Ascentage Pharma Group International | 1.44B | 10.13% | 14,544 | 94.61M |
| 128 | ANAB | AnaptysBio, Inc. | 1.43B | -2.66% | 627,091 | 106.09M |
| 129 | TSHA | Taysha Gene Therapies, Inc. | 1.43B | -2.23% | 4,835,616 | 5.49M |
| 130 | RARE | Ultragenyx Pharmaceutical Inc. | 1.42B | -0.28% | 3,892,009 | 717.00M |
| 131 | KLRA | Kailera Therapeutics, Inc. | 1.40B | -0.09% | 1,452,112 | - |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.39B | -3.30% | 763,384 | - |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -1.22% | 169,451 | 1.30M |
| 134 | NKTR | Nektar Therapeutics | 1.36B | -5.47% | 1,957,185 | 54.59M |
| 135 | OMER | Omeros Corporation | 1.34B | -2.06% | 1,034,975 | 38.42M |
| 136 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -2.75% | 427,518 | - |
| 137 | COAG | Hemab Therapeutics Holdings, Inc. | 1.33B | -7.26% | 436,833 | - |
| 138 | NBTX | Nanobiotix S.A. | 1.29B | 0.52% | 156,300 | 13.15M |
| 139 | KARD | Kardigan, Inc. | 1.26B | -11.48% | 1,560,902 | - |
| 140 | REPL | Replimune Group, Inc. | 1.25B | 0.76% | 2,617,971 | - |
| 141 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | -4.08% | 2,091,857 | - |
| 142 | DMRA | Damora Therapeutics, Inc. | 1.21B | -3.31% | 1,171,651 | - |
| 143 | MNKD | MannKind Corporation | 1.19B | -2.88% | 3,070,738 | 393.63M |
| 144 | SVRA | Savara Inc. | 1.18B | -2.72% | 2,291,156 | - |
| 145 | AVLN | Avalyn Pharma Inc. | 1.13B | -5.92% | 260,611 | - |
| 146 | TRAX | First Tracks Biotherapeutics, Inc. | 1.12B | -4.85% | 614,109 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.11B | -1.04% | 432,766 | - |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.10B | -4.22% | 981,198 | - |
| 149 | VOR | Vor Biopharma Inc. | 1.08B | -1.45% | 472,842 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.08B | -2.22% | 545,011 | - |
| 151 | CGEM | Cullinan Therapeutics, Inc. | 1.05B | 1.31% | 2,017,234 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.03B | 1.51% | 809,847 | 24.00M |
| 153 | IMTX | Immatics N.V. | 1.03B | -2.98% | 974,386 | 47.65M |
| 154 | MGTX | MeiraGTx Holdings plc | 1.02B | -2.93% | 944,436 | 397.50M |
| 155 | AKTS | Aktis Oncology, Inc. | 993.36M | -3.56% | 294,763 | 10.06M |
| 156 | KURA | Kura Oncology, Inc. | 936.76M | -0.85% | 1,309,741 | 77.23M |
| 157 | MLTX | MoonLake Immunotherapeutics | 931.92M | -3.78% | 3,052,430 | - |
| 158 | ANL | Adlai Nortye Group Ltd. | 931.19M | -3.86% | 99,767 | 18.06M |
| 159 | SPTX | Seaport Therapeutics, Inc. | 929.83M | -6.11% | 243,005 | - |
| 160 | ANRO | Alto Neuroscience, Inc. | 929.65M | -1.33% | 576,586 | - |
| 161 | ALMS | Alumis Inc. | 896.99M | 1.32% | 1,745,543 | 7.40M |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 888.32M | -1.68% | 1,441,149 | - |
| 163 | ABUS | Arbutus Biopharma Corporation | 886.36M | -4.07% | 8,259,929 | 181.72M |
| 164 | ODTX | Odyssey Therapeutics, Inc. | 868.76M | -13.00% | 340,863 | 99.00K |
| 165 | SLBT | SL Science Holding Limited | 866.80M | -4.40% | 52,253 | 3.27M |
| 166 | RIGL | Rigel Pharmaceuticals, Inc. | 861.33M | -3.52% | 202,599 | 276.79M |
| 167 | JBIO | Jade Biosciences, Inc. | 852.84M | -4.69% | 493,865 | - |
| 168 | GLUE | Monte Rosa Therapeutics, Inc. | 842.04M | -3.89% | 1,052,878 | 28.73M |
| 169 | DNA | Ginkgo Bioworks Holdings, Inc. | 835.69M | -17.16% | 13,137,636 | 132.42M |
| 170 | SGP | SpyGlass Pharma, Inc. | 828.84M | -3.17% | 81,206 | - |
| 171 | ARDX | Ardelyx, Inc. | 824.81M | -2.36% | 5,818,809 | 450.89M |
| 172 | SANA | Sana Biotechnology, Inc. | 823.24M | -4.51% | 3,759,385 | - |
| 173 | OBX | Obsidian Therapeutics, Inc. | 816.64M | -4.48% | 288,797 | - |
| 174 | IMMX | Immix Biopharma, Inc. | 799.18M | -4.84% | 1,215,128 | - |
| 175 | ATTO | Attovia Therapeutics, Inc. | 798.90M | -2.78% | 521,653 | 1.80M |
| 176 | IVA | Inventiva S.A. | 789.20M | -0.57% | 2,200,398 | 2.81M |
| 177 | HELP | Helus Pharma Inc. | 786.13M | -5.78% | 1,479,051 | - |
| 178 | LXRX | Lexicon Pharmaceuticals, Inc. | 778.67M | 0.57% | 1,640,480 | 41.47M |
| 179 | GERN | Geron Corporation | 777.39M | - | 5,718,150 | 204.56M |
| 180 | APMD | Apnimed, Inc. | 776.41M | -14.25% | 581,295 | 115.12M |
| 181 | ANNX | Annexon, Inc. | 764.00M | -4.05% | 2,701,304 | - |
| 182 | CADL | Candel Therapeutics, Inc. | 755.24M | -3.52% | 977,769 | - |
| 183 | GYRE | Gyre Therapeutics, Inc. | 750.72M | -3.67% | 133,971 | 109.82M |
| 184 | DSGN | Design Therapeutics, Inc. | 749.10M | -3.62% | 642,531 | - |
| 185 | AVBP | ArriVent BioPharma, Inc. | 744.05M | -46.98% | 19,752,235 | - |
| 186 | SLDB | Solid Biosciences Inc. | 742.00M | -1.98% | 1,188,693 | - |
| 187 | AVTX | Avalo Therapeutics, Inc. | 728.83M | -6.92% | 955,580 | 59.00K |
| 188 | ACHV | Achieve Life Sciences, Inc. | 723.40M | 0.29% | 1,056,467 | - |
| 189 | VSTM | Verastem, Inc. | 701.87M | -3.13% | 2,513,883 | 87.53M |
| 190 | FTH | Faeth Therapeutics, Inc. | 694.85M | -0.77% | 289,151 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 693.87M | -2.79% | 1,170,871 | 92.01M |
| 192 | WVE | Wave Life Sciences, Inc. | 693.61M | -6.13% | 3,450,688 | 65.37M |
| 193 | OLMA | Olema Pharmaceuticals, Inc. | 692.98M | -4.00% | 1,038,942 | - |
| 194 | PHAR | Pharming Group N.V. | 691.60M | -1.22% | 6,726 | 366.48M |
| 195 | MDXG | MiMedx Group, Inc. | 673.41M | 1.54% | 1,050,128 | 355.17M |
| 196 | NVCT | Nuvectis Pharma, Inc. | 652.61M | -6.36% | 188,081 | - |
| 197 | AURA | Aura Biosciences, Inc. | 639.86M | -0.80% | 607,526 | - |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 637.19M | 0.28% | 614,595 | 136.07M |
| 199 | OABI | OmniAb, Inc. | 632.45M | -11.59% | 2,002,426 | 38.46M |
| 200 | PRME | Prime Medicine, Inc. | 622.67M | 9.03% | 12,022,399 | 4.07M |
| 201 | SGMT | Sagimet Biosciences Inc. | 621.16M | -2.99% | 896,376 | - |
| 202 | ETRA | Electra Therapeutics, Inc. | 616.37M | 0.82% | 276,155 | - |
| 203 | CLYM | Climb Bio, Inc. | 613.42M | -3.35% | 954,530 | - |
| 204 | SLN | Silence Therapeutics plc | 591.86M | -3.06% | 1,583,356 | 615.00K |
| 205 | DBVT | DBV Technologies S.A. | 590.36M | -4.41% | 558,006 | 5.04M |
| 206 | STTK | Shattuck Labs, Inc. | 588.13M | -9.85% | 1,595,354 | 1.00M |
| 207 | CBIO | Crescent Biopharma, Inc. | 580.81M | -2.65% | 492,370 | 11.88M |
| 208 | CRMD | CorMedix Inc. | 567.43M | 0.28% | 744,256 | 462.25M |
| 209 | CTMX | CytomX Therapeutics, Inc. | 557.82M | -0.78% | 1,955,984 | 18.30M |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 549.56M | -13.29% | 247,369 | - |
| 211 | VALN | Valneva SE | 547.98M | 0.69% | 19,056 | 163.30M |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 544.64M | -13.35% | 3,531,029 | 8.22M |
| 213 | PHAT | Phathom Pharmaceuticals, Inc. | 538.54M | 1.19% | 2,087,959 | 239.66M |
| 214 | MPLT | MapLight Therapeutics, Inc. | 538.53M | 4.42% | 495,595 | - |
| 215 | OCS | Oculis Holding AG | 538.30M | 1.87% | 291,650 | 1.45M |
| 216 | MNPR | Monopar Therapeutics Inc. | 534.09M | 1.63% | 302,176 | - |
| 217 | ALT | Altimmune, Inc. | 519.36M | - | 7,627,410 | 31.00K |
| 218 | EPRX | Eupraxia Pharmaceuticals Inc. | 510.29M | -0.13% | 1,636,359 | - |
| 219 | NGNE | Neurogene Inc. | 509.29M | -3.85% | 121,652 | 925.00K |
| 220 | ALLO | Allogene Therapeutics, Inc. | 504.42M | -2.67% | 4,659,679 | 4.64M |
| 221 | RGNX | REGENXBIO Inc. | 491.80M | -3.99% | 1,164,413 | 174.48M |
| 222 | PBYI | Puma Biotechnology, Inc. | 490.39M | -1.76% | 322,658 | 231.24M |
| 223 | PROK | ProKidney Corp. | 483.72M | 1.27% | 771,314 | 818.00K |
| 224 | DRUG | Bright Minds Biosciences Inc. | 480.02M | -3.09% | 107,660 | - |
| 225 | ARVN | Arvinas, Inc. | 477.97M | -2.01% | 585,799 | 316.70M |
| 226 | AUTL | Autolus Therapeutics plc | 476.43M | -2.19% | 1,682,568 | 117.39M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 475.91M | -0.55% | 761,922 | - |
| 228 | OVID | Ovid Therapeutics Inc. | 462.86M | 1.28% | 1,735,015 | 1.58M |
| 229 | RZLT | Rezolute, Inc. | 453.15M | -0.23% | 2,191,788 | - |
| 230 | ASMB | Assembly Biosciences, Inc. | 451.60M | -2.46% | 349,445 | 74.85M |
| 231 | CAPR | Capricor Therapeutics, Inc. | 450.58M | -0.39% | 3,132,726 | 11.13M |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 438.42M | -3.44% | 242,316 | - |
| 233 | TECX | Tectonic Therapeutic, Inc. | 438.10M | -3.03% | 200,937 | - |
| 234 | ENTX | Entera Bio Ltd. | 438.05M | -3.44% | 621,168 | 42.00K |
| 235 | YDES | YD Bio Limited | 435.61M | -13.50% | 439,690 | 1.24M |
| 236 | AGMB | AgomAb Therapeutics NV | 435.35M | 1.73% | 103,921 | - |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 427.13M | 0.12% | 1,219,176 | 116.93M |
| 238 | EDIT | Editas Medicine, Inc. | 419.27M | -2.15% | 2,968,621 | 47.01M |
| 239 | PRTA | Prothena Corporation plc | 411.72M | -3.02% | 510,608 | 54.53M |
| 240 | EIKN | Eikon Therapeutics, Inc. | 406.78M | -0.40% | 611,020 | - |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 406.64M | -1.17% | 229,368 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 392.41M | 1.06% | 383,740 | 22.42M |
| 243 | KYTX | Kyverna Therapeutics, Inc. | 380.96M | -2.53% | 739,522 | - |
| 244 | ZURA | Zura Bio Limited | 379.48M | 0.76% | 1,427,414 | - |
| 245 | GALT | Galectin Therapeutics Inc. | 379.19M | 0.80% | 277,933 | - |
| 246 | VTVT | vTv Therapeutics Inc. | 373.12M | -0.99% | 27,930 | 36.84M |
| 247 | ARCT | Arcturus Therapeutics Holdings Inc. | 369.50M | -11.32% | 885,092 | 29.37M |
| 248 | IRD | Opus Genetics, Inc. | 364.40M | - | 2,536,785 | 9.86M |
| 249 | FENC | Fennec Pharmaceuticals Inc. | 362.95M | -2.54% | 99,077 | 59.22M |
| 250 | IKT | Inhibikase Therapeutics, Inc. | 360.51M | -1.00% | 583,838 | 1.00 |
| 251 | ARTV | Artiva Biotherapeutics, Inc. | 355.43M | 1.96% | 665,417 | 251.00K |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 354.46M | -3.41% | 271,697 | 65.26M |
| 253 | CCCC | C4 Therapeutics, Inc. | 354.31M | -3.68% | 2,114,454 | 35.04M |
| 254 | OCGN | Ocugen, Inc. | 352.67M | - | 5,293,893 | 4.58M |
| 255 | OBIO | Orchestra BioMed Holdings, Inc. | 351.01M | -3.15% | 213,124 | 31.98M |
| 256 | RLMD | Relmada Therapeutics, Inc. | 349.88M | -5.75% | 1,735,689 | - |
| 257 | TTRX | Turn Therapeutics Inc. | 346.73M | -5.83% | 74,849 | - |
| 258 | INDP | Indaptus Therapeutics, Inc. | 345.10M | 3.19% | 279,293 | - |
| 259 | CABA | Cabaletta Bio, Inc. | 342.48M | -2.88% | 4,134,809 | - |
| 260 | AGEN | Agenus Inc. | 337.20M | -14.20% | 1,527,349 | 132.69M |
| 261 | BNTC | Benitec Biopharma Inc. | 313.94M | -2.49% | 217,153 | - |
| 262 | SRZN | Surrozen, Inc. | 309.94M | -9.47% | 603,824 | 11.51M |
| 263 | SCTX | Scribe Therapeutics Inc. | 309.15M | 0.74% | 464,578 | 33.30M |
| 264 | LRMR | Larimar Therapeutics, Inc. | 290.18M | -2.80% | 829,229 | - |
| 265 | ABEO | Abeona Therapeutics Inc. | 286.49M | -1.96% | 1,428,112 | 25.52M |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 286.24M | -1.22% | 3,547 | 65.05M |
| 267 | FULC | Fulcrum Therapeutics, Inc. | 281.54M | -0.54% | 757,034 | 80.00M |
| 268 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 280.61M | -2.78% | 660,105 | - |
| 269 | XFOR | X4 Pharmaceuticals, Inc. | 274.64M | -4.48% | 642,468 | 15.85M |
| 270 | FATE | Fate Therapeutics, Inc. | 274.39M | -5.76% | 1,135,796 | 6.49M |
| 271 | EYPT | EyePoint, Inc. | 273.29M | 0.63% | 1,977,448 | 2.79M |
| 272 | VNDA | Vanda Pharmaceuticals Inc. | 273.29M | -1.31% | 1,801,117 | 215.72M |
| 273 | RCKT | Rocket Pharmaceuticals, Inc. | 272.24M | -4.98% | 1,790,517 | - |
| 274 | LXEO | Lexeo Therapeutics, Inc. | 270.74M | -3.23% | 1,538,803 | - |
| 275 | SABS | SAB Biotherapeutics, Inc. | 266.59M | -5.48% | 663,651 | 114.70K |
| 276 | BCYC | Bicycle Therapeutics plc | 265.27M | -5.49% | 620,680 | 61.21M |
| 277 | PALI | Palisade Bio, Inc. | 259.66M | 2.05% | 1,972,736 | 500.00K |
| 278 | VCRE | Vicore Pharma Holding AB (publ) | 252.82M | -2.89% | 22,840 | 412.09K |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 252.77M | -3.96% | 827,895 | 26.87M |
| 280 | UPB | Upstream Bio, Inc. | 251.40M | -5.36% | 1,062,306 | 3.16M |
| 281 | ACIU | AC Immune SA | 250.56M | -7.01% | 277,841 | 21.67M |
| 282 | CAMP | Camp4 Therapeutics Corporation | 248.50M | -1.25% | 1,231,130 | 4.22M |
| 283 | IMRX | Immuneering Corporation | 247.79M | -5.20% | 898,442 | - |
| 284 | SLGL | Sol-Gel Technologies Ltd. | 247.65M | -4.19% | 43,975 | 1.80M |
| 285 | VOGX | Vogenx, Inc. | 243.47M | -4.43% | 27,081 | - |
| 286 | QTTB | Q32 Bio Inc. | 241.43M | -3.11% | 678,816 | 53.74M |
| 287 | PYXS | Pyxis Oncology, Inc. | 241.30M | -9.82% | 1,405,476 | 11.04M |
| 288 | EVMN | Evommune, Inc. | 239.89M | -0.60% | 1,007,360 | 10.00M |
| 289 | STRO | Sutro Biopharma, Inc. | 239.60M | -4.49% | 162,793 | 45.70M |
| 290 | IPSC | Century Therapeutics, Inc. | 239.02M | -10.81% | 2,715,586 | 109.16M |
| 291 | IVVD | Invivyd, Inc. | 237.69M | -3.91% | 5,048,786 | 58.37M |
| 292 | LCTX | Lineage Cell Therapeutics, Inc. | 237.20M | 1.13% | 967,621 | 13.08M |
| 293 | PRQR | ProQR Therapeutics N.V. | 232.85M | -1.20% | 504,649 | 21.05M |
| 294 | IFRX | InflaRx N.V. | 232.84M | -5.95% | 720,672 | -11.54K |
| 295 | MGNX | MacroGenics, Inc. | 231.87M | -3.45% | 633,291 | 175.14M |
| 296 | GLSI | Greenwich LifeSciences, Inc. | 231.77M | -6.62% | 113,650 | - |
| 297 | NAUT | Nautilus Biotechnology, Inc. | 225.24M | -5.35% | 11,022,084 | 190.00K |
| 298 | PLX | Protalix BioTherapeutics, Inc. | 219.96M | 0.74% | 934,737 | 80.62M |
| 299 | KROS | Keros Therapeutics, Inc. | 218.30M | -4.43% | 185,318 | 15.01M |
| 300 | SION | Sionna Therapeutics, Inc. | 214.76M | -2.06% | 1,261,138 | - |
| 301 | LYEL | Lyell Immunopharma, Inc. | 210.99M | -5.07% | 125,040 | 27.00K |
| 302 | CGEN | Compugen Ltd. | 210.29M | -3.90% | 265,380 | 74.00M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 205.80M | -2.43% | 468,158 | 7.15M |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 204.22M | -5.46% | 171,212 | 1.48M |
| 305 | ALEC | Alector, Inc. | 202.10M | -9.05% | 10,177,270 | 13.86M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 199.29M | -2.00% | 830,326 | - |
| 307 | ADAG | Adagene Inc. | 196.73M | 4.64% | 213,515 | 9.29M |
| 308 | ACOG | Alpha Cognition Inc. | 195.57M | -1.86% | 87,040 | 15.26M |
| 309 | TRDA | Entrada Therapeutics, Inc. | 195.43M | -1.09% | 315,919 | 4.69M |
| 310 | ANTX | AN2 Therapeutics, Inc. | 191.32M | -9.63% | 318,215 | - |
| 311 | NGEN | NervGen Pharma Corp. | 188.16M | -3.31% | 297,809 | - |
| 312 | CNTN | Canton Strategic Holdings, Inc. | 186.45M | 0.43% | 531,548 | 1.50M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 182.20M | -3.74% | 96,232 | 2.00M |
| 314 | CMPX | Compass Therapeutics, Inc. | 179.75M | 3.90% | 7,286,326 | 850.00K |
| 315 | YARW | Yarrow Bioscience, Inc. | 174.27M | -7.73% | 69,156 | - |
| 316 | DTIL | Precision BioSciences, Inc. | 171.13M | -1.74% | 190,958 | 45.06M |
| 317 | MDWD | MediWound Ltd. | 169.77M | -2.66% | 58,786 | 11.86M |
| 318 | CUE | Cue Biopharma, Inc. | 168.10M | -5.01% | 174,849 | 37.66M |
| 319 | NKTX | Nkarta, Inc. | 165.45M | -8.70% | 754,798 | - |
| 320 | NERV | Minerva Neurosciences, Inc. | 163.77M | 3.31% | 105,309 | - |
| 321 | NBP | NovaBridge Biosciences | 162.40M | 2.94% | 379,837 | - |
| 322 | MSLE | Satellos Bioscience Inc. | 160.69M | -6.34% | 48,081 | - |
| 323 | PEPG | PepGen Inc. | 159.99M | -2.12% | 590,170 | - |
| 324 | CHRS | Coherus Oncology, Inc. | 159.14M | -8.04% | 2,972,877 | 50.94M |
| 325 | ALXO | ALX Oncology Holdings Inc. | 153.49M | -8.26% | 1,014,121 | - |
| 326 | VRXA | Veraxa Biotech AG | 152.72M | -4.42% | 395,268 | 29.54K |
| 327 | MOLN | Molecular Partners AG | 152.63M | -3.57% | 4,842 | 856.30K |
| 328 | VYGR | Voyager Therapeutics, Inc. | 151.58M | - | 617,754 | 34.46M |
| 329 | TARA | Protara Therapeutics, Inc. | 150.99M | -2.85% | 803,565 | - |
| 330 | MENS | Jyong Biotech Ltd. | 149.95M | -1.46% | 20,186 | - |
| 331 | CDXS | Codexis, Inc. | 148.93M | -2.16% | 597,871 | 77.68M |
| 332 | AVXL | Anavex Life Sciences Corp. | 148.31M | -2.74% | 1,435,118 | - |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 146.80M | -4.69% | 562,869 | - |
| 334 | KRRO | Korro Bio, Inc. | 143.72M | -2.11% | 142,621 | 2.38M |
| 335 | TLSA | Tiziana Life Sciences Ltd | 143.53M | 3.74% | 634,192 | - |
| 336 | ARMP | Armata Pharmaceuticals, Inc. | 143.15M | 5.19% | 114,681 | 5.54M |
| 337 | IPHA | Innate Pharma S.A. | 139.54M | 0.63% | 133,729 | 11.21M |
| 338 | OTLK | Outlook Therapeutics, Inc. | 139.25M | -3.95% | 3,164,191 | -1.16M |
| 339 | RNA | Atrium Therapeutics, Inc. | 136.67M | 0.25% | 411,686 | 35.84M |
| 340 | HUMA | Humacyte, Inc. | 132.79M | -4.40% | 4,281,128 | 2.12M |
| 341 | TNXP | Tonix Pharmaceuticals Holding Corp. | 131.98M | -4.65% | 2,538,795 | 29.10M |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 127.19M | 2.44% | 418,911 | 3.39M |
| 343 | KZIA | Kazia Therapeutics Limited | 126.90M | -0.96% | 129,944 | 1.27M |
| 344 | HURA | TuHURA Biosciences, Inc. | 124.27M | 4.28% | 181,695 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 122.96M | -5.80% | 101,894 | 697.00K |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 122.54M | -3.12% | 2,703,449 | 1.34M |
| 347 | CRBU | Caribou Biosciences, Inc. | 121.68M | -4.62% | 5,939,337 | 10.04M |
| 348 | PMVP | PMV Pharmaceuticals, Inc. | 121.58M | -9.55% | 616,109 | - |
| 349 | SEER | Seer, Inc. | 121.26M | -6.01% | 144,329 | 14.22M |
| 350 | ENGN | enGene Therapeutics Inc. | 120.63M | -3.74% | 361,658 | - |
| 351 | CBUS | Cibus, Inc. | 119.99M | -6.55% | 164,426 | 4.35M |
| 352 | LENZ | LENZ Therapeutics, Inc. | 119.08M | 5.57% | 682,818 | 21.48M |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 117.83M | 0.95% | 786,417 | - |
| 354 | FHTX | Foghorn Therapeutics Inc. | 116.99M | -1.50% | 984,693 | 36.74M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 116.84M | -1.74% | 2,013,261 | 65.34K |
| 356 | RANI | Rani Therapeutics Holdings, Inc. | 115.53M | 6.96% | 961,665 | 4.88M |
| 357 | GNLX | Genelux Corporation | 113.82M | -2.31% | 77,648 | 8.00K |
| 358 | COYA | Coya Therapeutics, Inc. | 113.77M | - | 94,629 | 8.02M |
| 359 | VANI | Vivani Medical, Inc. | 111.85M | 1.64% | 100,709 | - |
| 360 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 111.79M | -1.20% | 707,588 | - |
| 361 | TENX | Tenax Therapeutics, Inc. | 110.55M | -1.53% | 1,183,569 | - |
| 362 | AARD | Aardvark Therapeutics, Inc. | 110.30M | -3.45% | 251,856 | - |
| 363 | MIST | Milestone Pharmaceuticals Inc. | 107.68M | -1.95% | 1,398,670 | 2.34M |
| 364 | IMUX | Immunic, Inc. | 106.70M | -3.10% | 347,887 | - |
| 365 | ANIX | Anixa Biosciences, Inc. | 104.99M | 2.37% | 344,956 | - |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 104.68M | 1.45% | 6,040 | - |
| 367 | PYPD | PolyPid Ltd. | 104.20M | -1.35% | 86,558 | - |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 103.42M | -7.22% | 840,849 | 70.00M |
| 369 | CNXU | Conexeu Sciences Inc. | 103.24M | 17.31% | 334,320 | - |
| 370 | CLLS | Cellectis S.A. | 102.20M | -0.71% | 75,789 | 63.82M |
| 371 | TVGN | Tevogen Inc. | 102.13M | -1.67% | 2,839 | - |
| 372 | OKUR | OnKure Therapeutics, Inc. | 99.62M | -6.46% | 327,499 | - |
| 373 | ATRA | Atara Biotherapeutics, Inc. | 97.87M | 3.72% | 47,599 | 6.19M |
| 374 | RLYB | Rallybio Corporation | 90.70M | 1.07% | 1,858 | 646.00K |
| 375 | BMEA | Biomea Fusion, Inc. | 90.60M | -3.85% | 797,006 | - |
| 376 | ICCC | ImmuCell Corporation | 90.55M | 2.26% | 832 | 30.68M |
| 377 | EQ | Equillium, Inc. | 90.04M | -2.07% | 393,616 | 4.39M |
| 378 | CGTX | Cognition Therapeutics, Inc. | 89.39M | 0.20% | 330,513 | - |
| 379 | NMRA | Neumora Therapeutics, Inc. | 88.50M | -10.34% | 1,234,489 | - |
| 380 | NRXS | NeurAxis, Inc. | 85.14M | -5.17% | 66,544 | 5.32M |
| 381 | CRDF | Cardiff Oncology, Inc. | 83.24M | -6.14% | 384,167 | 508.00K |
| 382 | PMN | ProMIS Neurosciences, Inc. | 82.59M | -1.71% | 26,459 | - |
| 383 | TELO | Telomir Pharmaceuticals, Inc. | 82.53M | -0.83% | 1,253,677 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 82.24M | 4.78% | 42,943 | 43.30M |
| 385 | MNOV | MediciNova, Inc. | 81.22M | -5.98% | 120,406 | 920.48K |
| 386 | NTRB | Nutriband Inc. | 81.20M | -10.58% | 87,019 | 1.62M |
| 387 | ACRV | Acrivon Therapeutics, Inc. | 79.71M | -6.06% | 158,748 | - |
| 388 | OKYO | OKYO Pharma Limited | 76.62M | -0.68% | 30,470 | - |
| 389 | ONCY | Oncolytics Biotech Inc. | 76.25M | 0.18% | 859,734 | - |
| 390 | PDSB | PDS Biotechnology Corporation | 75.74M | -12.92% | 17,042,595 | - |
| 391 | NTHI | NeOnc Technologies Holdings, Inc. | 74.32M | 2.40% | 173,713 | 39.99K |
| 392 | HYFT | MindWalk Holdings Corp. | 73.02M | 4.03% | 1,887,181 | 11.57M |
| 393 | GANX | Gain Therapeutics, Inc. | 72.88M | -1.18% | 646,563 | - |
| 394 | MAIA | MAIA Biotechnology, Inc. | 72.38M | 0.85% | 227,156 | - |
| 395 | VRCA | Verrica Pharmaceuticals Inc. | 72.32M | -2.32% | 41,314 | 30.32M |
| 396 | RNTX | Rein Therapeutics Inc. | 71.17M | - | 185,635 | - |
| 397 | CING | Cingulate Inc. | 71.11M | 2.95% | 111,672 | - |
| 398 | CSBR | Champions Oncology, Inc. | 69.73M | 0.80% | 16,314 | 60.66M |
| 399 | SPRO | Spero Therapeutics, Inc. | 69.30M | 2.59% | 347,570 | 47.00M |
| 400 | OSTX | OS Therapies Incorporated | 68.73M | -6.88% | 6,015,385 | - |
| 401 | FBIO | Fortress Biotech, Inc. | 68.37M | -1.91% | 223,986 | 68.47M |
| 402 | IBIO | iBio, Inc. | 67.52M | -6.25% | 1,210,345 | 100.00K |
| 403 | ACET | Adicet Bio, Inc. | 67.28M | -3.40% | 135,721 | - |
| 404 | GOSS | Gossamer Bio, Inc. | 65.87M | 1.22% | 197,220 | 53.29M |
| 405 | XBIT | XBiotech Inc. | 65.85M | -0.92% | 11,714 | - |
| 406 | ALPS | Alps Group Inc | 64.18M | -3.58% | 13,996 | 3.74M |
| 407 | ATHE | Alterity Therapeutics Limited | 63.98M | 4.66% | 21,857 | 2.50M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 63.78M | - | 276,386 | - |
| 409 | KLRS | Kalaris Therapeutics, Inc. | 63.32M | -6.01% | 103,434 | - |
| 410 | HRTX | Heron Therapeutics, Inc. | 62.97M | -10.35% | 2,319,194 | 151.18M |
| 411 | RNXT | RenovoRx, Inc. | 62.73M | -5.44% | 621,683 | 1.98M |
| 412 | ELOX | Eloxx Pharmaceuticals, Inc. | 61.07M | -1.82% | 61,290 | - |
| 413 | GUTS | Fractyl Health, Inc. | 60.62M | 0.22% | 156,724 | 3.00K |
| 414 | INKT | MiNK Therapeutics, Inc. | 59.71M | -4.10% | 33,075 | - |
| 415 | HYPD | Hyperion DeFi, Inc. | 59.36M | -1.80% | 267,709 | 1.40M |
| 416 | XLO | Xilio Therapeutics, Inc. | 59.22M | -1.21% | 6,198 | 64.09M |
| 417 | BOLD | Boundless Bio, Inc. | 58.46M | -1.15% | 65,185 | - |
| 418 | CNTB | Connect Biopharma Holdings Limited | 57.02M | 0.84% | 1,840,788 | 2.95M |
| 419 | MREO | Mereo BioPharma Group plc | 55.91M | -9.77% | 1,268,975 | 500.00K |
| 420 | ALDX | Aldeyra Therapeutics, Inc. | 55.25M | -0.84% | 8,234,453 | - |
| 421 | CLNN | Clene Inc. | 55.01M | -1.02% | 44,980 | 197.00K |
| 422 | LONA | LeonaBio, Inc. | 54.17M | 3.05% | 175,828 | - |
| 423 | IMA | ImageneBio, Inc. | 52.22M | -2.13% | 13,741 | 800.00K |
| 424 | INMB | INmune Bio Inc. | 51.90M | -3.61% | 311,074 | 50.00K |
| 425 | SER | Serina Therapeutics, Inc. | 51.82M | - | 8,720 | 130.00K |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 51.67M | - | 127,154 | - |
| 427 | CELU | Celularity Inc. | 51.27M | -7.60% | 260,947 | 18.97M |
| 428 | EXOZ | eXoZymes, Inc. | 51.23M | - | 1,833 | -700.00 |
| 429 | CRVO | CervoMed Inc. | 50.50M | 0.91% | 470,493 | 331.30K |
| 430 | ANVS | Annovis Bio, Inc. | 50.28M | -1.67% | 538,719 | - |
| 431 | EDSA | Edesa Biotech, Inc. | 50.26M | -4.86% | 12,830 | - |
| 432 | ELTX | Elicio Therapeutics, Inc. | 49.41M | -2.08% | 259,101 | - |
| 433 | APLM | Apollomics, Inc. | 48.53M | -5.03% | 13,177 | 8.84M |
| 434 | CVM | CEL-SCI Corporation | 48.19M | 13.22% | 470,190 | - |
| 435 | TIL | Instil Bio, Inc. | 46.69M | -0.94% | 24,192 | - |
| 436 | BSEM | BioStem Technologies, Inc. | 45.90M | -10.34% | 128,617 | 34.59M |
| 437 | HOWL | Werewolf Therapeutics, Inc. | 44.72M | -1.05% | 279,152 | 21.00M |
| 438 | GRCE | Grace Therapeutics, Inc. | 43.44M | 0.24% | 110,265 | - |
| 439 | LITS | Lite Strategy, Inc. | 42.87M | 0.71% | 493,960 | - |
| 440 | FLNA | Filana Therapeutics, Inc. | 42.26M | 0.59% | 671,499 | - |
| 441 | VERU | Veru Inc. | 42.11M | -3.14% | 1,518,550 | 16.89M |
| 442 | IBO | Impact BioMedical Inc. | 39.98M | -3.31% | 21,173 | 35.00K |
| 443 | MGX | Metagenomi Therapeutics, Inc. | 38.91M | -0.96% | 121,027 | 13.56M |
| 444 | NNVC | NanoViricides, Inc. | 35.74M | -3.45% | 303,310 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 34.90M | -7.50% | 439,576 | 35.09M |
| 446 | BCTX | BriaCell Therapeutics Corp. | 34.87M | -3.83% | 69,125 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 33.60M | -0.37% | 12,842 | 31.52M |
| 448 | IMMP | Immutep Limited | 30.87M | 1.64% | 11,618 | 13.79M |
| 449 | RNAZ | TransCode Therapeutics, Inc. | 30.14M | 1.14% | 47,337 | - |
| 450 | CNTX | Context Therapeutics Inc. | 29.57M | -4.37% | 898,947 | - |
| 451 | GRDX | GridAI Technologies Corp. | 29.53M | 8.88% | 105,200 | - |
| 452 | MCRB | Seres Therapeutics, Inc. | 29.13M | 1.75% | 76,422 | 1.88M |
| 453 | IGC | IGC Pharma, Inc. | 28.95M | -0.71% | 1,113,538 | 1.11M |
| 454 | BYSI | BeyondSpring Inc. | 28.47M | -11.92% | 117,249 | 1.88M |
| 455 | ATYR | aTyr Pharma, Inc. | 27.80M | -2.28% | 1,022,950 | 190.00K |
| 456 | QNCX | Quince Therapeutics, Inc. | 27.27M | -4.59% | 27,827 | - |
| 457 | EVAX | Evaxion A/S | 26.36M | 0.32% | 35,875 | 7.49M |
| 458 | NXTC | NextCure, Inc. | 26.02M | 12.57% | 122,586 | - |
| 459 | ABVC | ABVC BioPharma, Inc. | 25.15M | -1.02% | 92,419 | 797.92K |
| 460 | QNTM | Quantum BioPharma Ltd. | 24.99M | -5.50% | 627,075 | - |
| 461 | ATOS | Atossa Therapeutics, Inc. | 24.45M | - | 54,626 | - |
| 462 | KYNB | Kyntra Bio, Inc. | 24.13M | -2.13% | 13,679 | 4.62M |
| 463 | PLRZ | Polyrizon Ltd. | 23.48M | 4.42% | 6,245 | - |
| 464 | QNRX | Quoin Pharmaceuticals, Ltd. | 22.68M | 3.62% | 103,829 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 21.38M | - | 28,500 | 330.00K |
| 466 | ACTU | Actuate Therapeutics, Inc. | 19.49M | -7.24% | 337,679 | - |
| 467 | AKTX | Akari Therapeutics, Plc | 19.17M | -6.15% | 19,780 | - |
| 468 | PBM | Psyence Biomedical Ltd. | 19.15M | -1.18% | 51,188 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 18.67M | - | 16,456 | 1.17M |
| 470 | TCRX | TScan Therapeutics, Inc. | 18.67M | -6.74% | 609,550 | 7.11M |
| 471 | ESLA | Estrella Immunopharma, Inc. | 18.66M | -2.50% | 68,650 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 18.64M | -5.52% | 328,613 | - |
| 473 | PTN | Palatin Technologies, Inc. | 17.45M | -0.74% | 2,766 | 13.19M |
| 474 | LPCN | Lipocine Inc. | 17.31M | 1.45% | 12,778 | 1.57M |
| 475 | NCEL | NewcelX Ltd. | 17.10M | 3.52% | 7,213 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 16.84M | -4.72% | 77,139 | 3.55M |
| 477 | RADX | Radiopharm Theranostics Limited | 16.66M | -7.09% | 77,791 | 8.90M |
| 478 | DYAI | Dyadic International, Inc. | 16.52M | -0.15% | 30,375 | 3.80M |
| 479 | BCDA | BioCardia, Inc. | 16.05M | -2.75% | 113,421 | 3.00K |
| 480 | KPRX | Kiora Pharmaceuticals, Inc. | 15.91M | -1.19% | 20,203 | 20.00K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 15.68M | -1.47% | 46,339 | 345.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 14.94M | -1.74% | 64,434 | - |
| 483 | KPTI | Karyopharm Therapeutics Inc. | 14.74M | -3.07% | 1,178,981 | 146.62M |
| 484 | NIKI | Niki BioSolutions, Inc. | 14.57M | 4.87% | 7,520 | - |
| 485 | HIND | Vyome Holdings, Inc. | 14.46M | 6.74% | 13,740 | 129.73K |
| 486 | AEON | AEON Biopharma, Inc. | 14.45M | 7.30% | 2,269,102 | - |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 14.41M | -5.26% | 148,297 | - |
| 488 | CLRB | Cellectar Biosciences, Inc. | 14.27M | -9.58% | 219,435 | - |
| 489 | ICU | SeaStar Medical Holding Corporation | 14.06M | -10.14% | 292,910 | 1.71M |
| 490 | INAB | IN8bio, Inc. | 13.70M | -2.11% | 45,589 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 13.20M | -7.56% | 420,260 | 7.11M |
| 492 | PASG | Passage Bio, Inc. | 13.13M | -0.24% | 6,574 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 13.03M | -0.64% | 218,008 | - |
| 494 | DARE | Daré Bioscience, Inc. | 12.74M | -1.19% | 88,575 | 1.37M |
| 495 | PLUR | Pluri Inc. | 12.22M | -4.35% | 6,147 | 1.02M |
| 496 | LTRN | Lantern Pharma Inc. | 12.19M | 1.45% | 388,664 | - |
| 497 | CNSY | Cerenome, Inc. | 12.07M | 1.92% | 69,638 | 4.20M |
| 498 | BLRX | BioLineRx Ltd. | 11.78M | -1.20% | 22,868 | 1.39M |
| 499 | INTS | Intensity Therapeutics, Inc. | 11.59M | 2.90% | 7,451 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 11.55M | 0.34% | 131,771 | - |